眼科 ›› 2022, Vol. 31 ›› Issue (2): 130-134.doi: 10.13281/j.cnki.issn.1004-4469.2022.02.010

• 论著 • 上一篇    下一篇

康柏西普治疗视网膜中央静脉阻塞继发黄斑水肿的多焦ERG变化及与视力的相关性

王运昌  李荣荣  肖哲  蔡祎  魏子依  邵长亮  张梦鸽  赵慧然  王莉菲   

  1. 河北省眼科医院 河北省眼科重点实验室 河北省眼病治疗中心,邢台054001
  • 收稿日期:2021-11-12 出版日期:2022-03-25 发布日期:2022-03-25
  • 通讯作者: 王莉菲,Email:wlfhb @126.com

Function of macula and its correlation with visual acuity after intravitreal Conbercept for central retinal vein occlusion induced macular edema #br#

Wang Yunchang, Li Rongrong, Xiao Zhe, Cai Yi, Wei Ziyi, Shao Changliang, Zhang Mengge, Zhao Huiran, Wang Lifei   

  1. Heibei Eye Hospital, The Key Laboratory of Ocular of Heibei Province, the Treatment Centre of Ocular Disease of Hebei Province, Xingtai 054001, China
  • Received:2021-11-12 Online:2022-03-25 Published:2022-03-25
  • Contact: Wang Lifei, Email: wlfhb @126.com

摘要: 目的 探讨玻璃体注射康柏西普治疗非缺血性视网膜中央静脉阻塞继发黄斑水肿的黄斑功能变化及与预后视力的相关性。设计 前瞻性病例系列。 研究对象 2020年8-12月河北省眼科医院非缺血性视网膜中央静脉阻塞继发黄斑水肿31例31眼。方法  所有受试者均接受玻璃体注射康柏西普3+PRN模式治疗,于治疗前,治疗后1、3、6个月行OCTA黄斑区扫描检查以及mf-ERG检查。主要指标 最佳矫正视力(BCVA)(LogMAR),mf-ERG一环及二环的N1波峰时、P1波峰时、P1波反应密度,相关系数。结果 患者治疗后1、3、6个月BCVA分别为0.71±0.22、0.67±0.18、0.51±0.14,较治疗前的0.87±0.27均有提高(F=18.771,P=0.004)。治疗后1、3、6个月一环N1波峰时分别为(28.73±1.34)ms、(26.47±0.99)ms、(24.23±1.30)ms,均较治疗前的(31.69±2.80)ms缩短(F=86.023,P=0.007);一环P1波峰时分别为(48.68±4.01)ms、(46.43±3.35)ms、(43.59±3.69)ms,均较治疗前的(50.52±3.80)ms缩短(F=21.333,P=0.010);二环N1波峰时分别为(27.55±2.98)ms、(24.41±2.77)ms、(22.55±2.45)ms,均较治疗前的(29.89±3.04)ms缩短(F=38.566,P=0.002);二环P1波峰时分别为(46.81±2.97)ms、(44.67±3.36)ms、(39.09±2.77)ms,均较治疗前的(48.41±3.68)ms缩短(F=46.681,P=0.003)。治疗后1、3、6个月一环P1波反应密度分别为(21.01±4.70)nv/deg2、(23.25±3.98)nv/deg2、(27.42±6.01)nv/deg2,均较治疗前的(15.81±5.42)nv/deg2增加(F=26.622,P=0.001);二环P1波反应密度分别为(6.21±2.16)nv/deg2、(7.89±2.05)nv/deg2、(10.67±2.01)nv/deg2,均较治疗前的(4.00±1.47)nv/deg2增加(F=71.764,P=0.005)。治疗后6个月时BCVA与一环及二环N1波峰时无相关性(r=0.112,P=0.609;r=0.284,P=0.188),与一环及二环P1波峰时呈正相关(r=0.784,P=0.013;r=0.592,P=0.036),与一环及二环P1波反应密度呈负相关(r=-0.683,P=0.012;r =-0.853,P=0.010)。结论 康柏西普玻璃体3+PRN模式注射能改善非缺血性视网膜中央静脉阻塞继发黄斑水肿患者视力及多焦ERG检测的黄斑功能。(眼科,2022,31: 130-134)


关键词: 非缺血性视网膜中央静脉阻塞, 黄斑水肿, 康柏西普, 多焦视网膜电图

Abstract: Objective To study the function changes of macula and its correlates with visual acuity after intravitreal Conbercept for central retinal vein occlusion (CRVO) induced macular edema (ME). Design Prospective case series. Participants 31 patients (31 eyes) with ME secondary to non-ischemia CRVO were enrolled from August 2020 to December 2020. Methods All the subjects were received Conbercept 3+PRN intravitreal injections. Before treatment and 1, 3 and 6 months after treatment, OCTA and mf-ERG were checked. Main Outcome Measures Best corrected visual acuity(BCVA) (LogMAR), amplitude density of P1 wave and implicit time of P1, N1 wave from mf-ERG ring 1 and ring 2. Results Compared to the baseline (0.87±0.27), BCVA was greatly improved at 1, 3, 6 months after treatment (0.71±0.22, 0.67±0.18, 0.51±0.14, respectively) (F=18.771, P=0.004). The implicit time of N1 wave from ring 1 at baseline and each follow-up point was 31.69±2.80 ms, 28.73±1.34 ms, 26.47±0.99 ms, 24.23±1.30 ms, respectively (F=86.023, P=0.007). The implicit time of P1 wave from ring 1 at baseline and each follow-up point was 50.52±3.80 ms, 48.68±4.01 ms, 46.43±3.35 ms, 43.59±3.69 ms, respectively (F=21.333, P=0.010). The implicit time of N1 wave from ring 2 at baseline and each follow-up point was 29.89±3.04 ms, 27.55±2.98 ms, 24.41±2.77 ms, 22.55±2.45 ms, respectively (F=38.566, P=0.002). The implicit time of P1 wave from ring 2 at baseline and each follow-up point wase 48.41±3.68 ms, 46.81±2.97 ms, 44.67±3.36 ms, 39.09±2.77 ms, respectively (F=46.681, P=0.003). The amplitude density of P1 from ring 1 at baseline and each follow-up point was 15.81±5.42 nv/deg2, 21.01±4.70 nv/deg2, 23.25±3.98 nv/deg2, 27.42±6.01 nv/deg2, respectively (F=26.622, P=0.001). The amplitude density of P1 from ring 2 at baseline and each follow-up point was 4.00±1.47 nv/deg2, 6.21±2.16 nv/deg2, 7.89±2.05 nv/deg2, 10.67±2.01 nv/deg2, respectively (F=71.764, P=0.005). Pearson correlation analysis showed there was no correlations between BCVA and the implicit time of N1 (r=0.112, P=0.609; r=0.284 P=0.188). However there was positive correlations between BCVA and the implicit time of P1(r=0.784, P=0.013; r=0.592, P=0.036) and negative correlations between BCVA and the amplitude density of P1 (r=-0.683, P=0.012; r=-0.853, P=0.010) after treatment. Conclusion Conbercept 3 + PRN injection can improve visual acuity and measured by mf-ERG macular function in patients with macular edema secondary to non ischemic central retinal vein occlusion. (Ophthalmol CHN, 2022, 31: 130-134)


Key words: non-ischemia central retinal vein occlusion, macular edema, Conbercept, multifocal electroretinogram